{"associated_institutions":[],"authors_api_url":"https://scholar.citedevidence.com/v1/oa/institutions/I4210162644/authors","cited_by_count":1,"collaborators_api_url":"https://scholar.citedevidence.com/v1/oa/institutions/I4210162644/collaborators","country_code":"CN","counts_by_year":[{"cited_by_count":1,"oa_works_count":1,"works_count":1,"year":2017}],"counts_by_year_api_url":"https://scholar.citedevidence.com/v1/oa/institutions/I4210162644/counts_by_year","created_date":"2022-02-02T04:48:36.000Z","display_name":"Reasonable Software House (China)","display_name_acronyms":[],"display_name_alternatives":["Reasonable Software House (China)"],"geo":{"city":"Hong Kong","country":"China","country_code":"CN","geonames_city_id":"1819729","latitude":22.342906951904297,"longitude":114.14678955078125,"region":"Hong Kong"},"homepage_url":"http://rspread.hk/","id":"https://openalex.org/I4210162644","ids":{"grid":"grid.493719.1","openalex":"https://openalex.org/I4210162644","ror":"https://ror.org/04nh45n53","wikidata":null,"wikipedia":""},"image_thumbnail_url":null,"image_url":null,"is_super_system":false,"lineage":["https://openalex.org/I4210162644"],"repositories":[],"roles":[{"id":"https://openalex.org/I4210162644","role":"institution","works_count":1}],"ror":"https://ror.org/04nh45n53","summary_stats":{"2yr_mean_citedness":0,"h_index":1,"i10_index":0},"topic_share":[{"display_name":"Medical and Biological Sciences","domain":{"display_name":"Health Sciences","id":"https://openalex.org/domains/4"},"field":{"display_name":"Medicine","id":"https://openalex.org/fields/27"},"id":"https://openalex.org/T14134","subfield":{"display_name":"Anatomy","id":"https://openalex.org/subfields/2702"},"value":0.000012},{"display_name":"Inflammatory mediators and NSAID effects","domain":{"display_name":"Health Sciences","id":"https://openalex.org/domains/4"},"field":{"display_name":"Medicine","id":"https://openalex.org/fields/27"},"id":"https://openalex.org/T10678","subfield":{"display_name":"Pharmacology","id":"https://openalex.org/subfields/2736"},"value":0.0000074},{"display_name":"Rheumatoid Arthritis Research and Therapies","domain":{"display_name":"Health Sciences","id":"https://openalex.org/domains/4"},"field":{"display_name":"Medicine","id":"https://openalex.org/fields/27"},"id":"https://openalex.org/T10200","subfield":{"display_name":"Rheumatology","id":"https://openalex.org/subfields/2745"},"value":0.0000069}],"topics":[{"count":1,"display_name":"Rheumatoid Arthritis Research and Therapies","domain":{"display_name":"Health Sciences","id":"https://openalex.org/domains/4"},"field":{"display_name":"Medicine","id":"https://openalex.org/fields/27"},"id":"https://openalex.org/T10200","score":0.9208,"subfield":{"display_name":"Rheumatology","id":"https://openalex.org/subfields/2745"}},{"count":1,"display_name":"Inflammatory mediators and NSAID effects","domain":{"display_name":"Health Sciences","id":"https://openalex.org/domains/4"},"field":{"display_name":"Medicine","id":"https://openalex.org/fields/27"},"id":"https://openalex.org/T10678","score":0.9353,"subfield":{"display_name":"Pharmacology","id":"https://openalex.org/subfields/2736"}},{"count":1,"display_name":"Medical and Biological Sciences","domain":{"display_name":"Health Sciences","id":"https://openalex.org/domains/4"},"field":{"display_name":"Medicine","id":"https://openalex.org/fields/27"},"id":"https://openalex.org/T14134","score":0.935,"subfield":{"display_name":"Anatomy","id":"https://openalex.org/subfields/2702"}}],"type":"company","type_id":"https://openalex.org/institution-types/company","updated_date":"2026-02-06T19:53:56.000Z","works_api_url":"https://scholar.citedevidence.com/v1/oa/institutions/I4210162644/works","works_count":1}